1. Axillary lymph node response to neoadjuvant systemic therapy with dedicated axillary hybrid 18F-FDG PET/MRI in clinically node-positive breast cancer patients: a pilot study. Issue 10 (October 2022) Authors: de Mooij, C.M.; Samiei, S.; Mitea, C.; Lobbes, M.B.I.; Kooreman, L.F.S.; Heuts, E.M.; Beets-Tan, R.G.H.; van Nijnatten, T.J.A.; Smidt, M.L. Journal: Clinical radiology Issue: Volume 77:Issue 10(2022) Page Start: e732 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Imaging findings for response evaluation of ductal carcinoma in situ in breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis. (November 2022) Authors: Ploumen, R.; de Mooij, C.M.; Gommers, S.; Keymeulen, K.; Smidt, M.; van Nijnatten, T. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗